AccuLine Ltd.
Digital Health — Stage: R&D. Est: 2022. Tags: Analysis, Artificial Intelligence, Cardiology, Detection, Diagnostics, Healthtech, Life Sciences, Machine Learning, Medical Devices, MedTech, Non Invasive, Preventive Medicine, Stress. AccuLine is a developer of a non-invasive examination technology, designed to detect coronary artery disease (CAD), aiming to replace the inaccurate ECG stress test exams. The company's platform, CORA, offers an accurate, swift and cost-effective alternative to traditional stress test examinations, enabling healthcare providers to prevent heart attacks by replacing inaccurate and labor-intensive methods.. Web: https://acculine-medical.com